| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 732.90M | 700.00M | 745.50M | 795.10M | 755.90M | 761.00M |
| Gross Profit | 300.00M | 594.60M | 627.10M | 663.90M | 625.10M | 336.70M |
| EBITDA | 212.70M | 221.40M | 231.20M | 286.10M | 224.60M | 214.80M |
| Net Income | 158.00M | 150.10M | 163.80M | 205.30M | 154.40M | 155.40M |
Balance Sheet | ||||||
| Total Assets | 13.64B | 12.21B | 10.81B | 11.68B | 9.90B | 7.65B |
| Cash, Cash Equivalents and Short-Term Investments | 351.40M | 11.79B | 10.34B | 11.18B | 9.40B | 7.22B |
| Total Debt | 153.40M | 86.60M | 102.70M | 109.40M | 110.40M | 101.60M |
| Total Liabilities | 13.25B | 11.84B | 10.46B | 11.34B | 9.65B | 7.50B |
| Stockholders Equity | 390.80M | 373.40M | 349.80M | 341.50M | 253.20M | 150.70M |
Cash Flow | ||||||
| Free Cash Flow | 210.20M | 314.00M | 73.40M | 653.20M | 440.00M | 800.20M |
| Operating Cash Flow | 214.40M | 318.40M | 74.60M | 654.60M | 459.40M | 813.60M |
| Investing Cash Flow | -6.80M | -7.80M | 2.40M | -393.10M | -408.70M | -672.00M |
| Financing Cash Flow | -163.90M | -165.40M | -164.30M | -145.70M | -68.90M | -199.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £4.15B | 5.71 | 41.35% | 5.93% | 4.28% | 5.18% | |
77 Outperform | £3.34B | 9.24 | 6.50% | 7.21% | -7.11% | 0.45% | |
76 Outperform | £8.88B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £2.31B | 20.62 | 8.35% | 3.40% | -28.04% | -102.43% | |
70 Outperform | £2.06B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
52 Neutral | £6.47B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |